Keywords: aronex, atragen, denied, fda, again, pharmaceuticals, lost

Aronex' Atragen denied by FDA again

Article | 10 January 2001

Print This

Aronex Pharmaceuticals lost three-quarters of its share price value at astroke after the US Food and Drug Administration declined, for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in